T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
53 hedge funds and large institutions have $24.5M invested in T2 Biosystems, Inc in 2020 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 7 closing their positions.
143% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 7
100% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 7
68% more call options, than puts
Call options by funds: $611K | Put options by funds: $363K
29% more capital invested
Capital invested by funds: $19M → $24.5M (+$5.56M)
15% more funds holding
Funds holding: 46 → 53 (+7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$897K |
| 2 |
BlackRock
New York
|
+$838K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$838K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$408K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$393K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$274K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$185K |
| 3 |
AIP
ARS Investment Partners
New York
|
-$133K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$126K |
| 5 |
GS
Gagnon Securities
New York
|
-$66.7K |
TTOO Hedge Fund Activity: Q3 2020 in Review
53 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q3 2020, worth a combined $24.5M — up 29% from $19M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new TTOO positions and 7 closed out — a net gain of 7 holders — while 17 added to existing stakes and 7 trimmed.
The largest buyer was Vanguard Group, adding an estimated $897K. The largest seller was Susquehanna International Group, cutting an estimated $274K.
- 53 institutional investors held T2 Biosystems, Inc (TTOO) as of Q3 2020, up from 46 in Q2 2020.
- Funds reported $24.5M of T2 Biosystems, Inc stock for Q3 2020, up 29% quarter-over-quarter.
- 14 funds opened new T2 Biosystems, Inc positions in Q3 2020 and 7 closed out, a net change of +7 holders.
- The largest T2 Biosystems, Inc buyer in Q3 2020 was Vanguard Group, an estimated $897K added.
- The largest T2 Biosystems, Inc seller in Q3 2020 was Susquehanna International Group, an estimated $274K sold.
Based on aggregated 13F filings for Q3 2020.